fcalabro

[fcalabro @fcala4]

@tompowles1 @Annals_Oncology In NMIBC?

[fcalabro @fcala4]

@DrIacovelli @aimac_it @AIOMtweet @siuroIT @kidneycan @IKCCorg @KidneyCancer Only for “certain”

[fcalabro @fcala4]

@tompowles1 The dose intensity for cisplatin in the dd-mvac regimen is at least 25% higher than in the ddp-gem arm. No true comparison is therefore possible

[Laid Back Llamas @LaidBackLlIamas]

Everyone is invited to claim airdrop.

A special surprise awaits on the blockchain....

https://t.co/Hm45ae1jMO

[mfers @unoffcialmfers]

Everyone is invited to claim airdrop.

A special surprise awaits on the blockchain....

https://t.co/gUrNKjbUdp

[Eric Cryptoman @EricCryptoman]

The @gambitgames_arb KOL TG is now muted after concerns were raised, @50senteth has identical excuses to @0xnickfury leading me to believe they are the same team & will come out with excuses soon.

If they don't hard rug it'll prob be ded within 1 week of launch. DYOR fellas.

[Jay @jayemgreen]

🎁#NFTGiveaway🎁

@BushidoRoyale was kind enough to give me 2 NFTs (free mint) to giveaway!

🏆2 NFTs🏆

To Enter✅
1⃣Join discord https://t.co/K6YbAyGEsv
2⃣Follow @BushidoRoyale
3⃣RT & Tag Frens

Founder is a fully doxxed BAYC holder, probably nothin...

#NFT #NFTGiveaway

[Jay @jayemgreen]

🎁#NFTGiveaway🎁

Partnered w/ @TheDeviantsNFT to giveaway 2 Silver Mint passes!

To Enter✅
1⃣Join https://t.co/bKgulMJVYp
2⃣Follow @TheDeviantsNFT
3⃣RT & Tag Frens

Free claim Deviants by burning the mint pass TODAY March 15th 4PM UTC 🗓️👀

[Undeads Games @Undeadscom]

🔥 11 ETH GIVEAWAY BY @Undeadscom🔥

💰WIN UP TO 1.1 ETH FROM 11 ETH PRIZE POOL!

💎 X10 PRIZES & MEMBER BENEFITS for #NFT HOLDERS

🔽 JOIN THE DRAW NOW:

https://t.co/qrnG8fmKFn

#NFTDrops #NFTGiveaways #NFTcommunity #Crypto #Web3 #Metaverse #Giveaway #Minting #Undeads

[Tom Powles @tompowles1]

FORT-1 tested rogaratinib vs chemotherapy in FGFR1/3 +ve(RNA) platinum refractory UC. 600 patients screened 175 randomised (60% biomarker +ve?) Efficacy results showed regimens were very similar. Erdafitinib has a better biomarker plan. Randomised trials with erda may still be OK

[fcalabro @fcala4]

@Uromigos @PGrivasMDPhD @kalasri3 @DrRosenbergMSK @MattGalsky @tompowles1 @brian_rini @UChicago @DrRanaMcKay @DrChoueiri @Prof_Nick_James @xiaoweimd @VUMC_Cancer @fredhutch @pmcancercentre @BartsECMC @MSK_DeptOfMed Is it possible that sequencing chemo and immunotherapy should be better than giving them together?

[Tom Powles @tompowles1]

Summary of 1st line advanced UC IO/chemo trials. IO can’t beat chemo and the PD-L1 biomarker doesn’t help. Chemo/IO (361,130) and Ipi/nivo in PD-L1+ve (901) were disappointing. 3 chemo/IO studies awaited for final OS, but existing data isn’t good. Still a chance for tremilimumab?

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

From the methodical and brilliant @ChrisSweens1 — this reflects my own practice @utswcancer for metastatic hormone sensitive #prostatecancer. #EAU22

[fcalabro @fcala4]

@tompowles1 And what about belzutifan? Di you think there is a room for this drug in the adiuvante setting?

[fcalabro @fcala4]

@Pennacchiiiii Con ogni mezzo! È uno dei beni più preziosi che abbiamo

[fcalabro @fcala4]

@paolonori Bellissimo. Un libro che fa piangere

[fcalabro @fcala4]

Mi piacerebbe conoscere il pensiero di #paolonori su questo libro